OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action
Caitlin M. Tilsed, Scott Fisher, Anna K. Nowak, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 93

Showing 1-25 of 93 citing articles:

Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Hao Zhang, Lin Liu, Jinbo Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 166

Beyond matrix stiffness: targeting force-induced cancer drug resistance
Maria Kalli, Matthew D. Poskus, Triantafyllos Stylianopoulos, et al.
Trends in cancer (2023) Vol. 9, Iss. 11, pp. 937-954
Open Access | Times Cited: 50

Carbon nanotube-mediated platinum-based drug delivery for the treatment of cancer: Advancements and future perspectives
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazeer Hasan, et al.
European Polymer Journal (2024) Vol. 206, pp. 112800-112800
Closed Access | Times Cited: 22

Recent Advances in the Development of Drug Delivery Applications of Magnetic Nanomaterials
Alexandra Pusta, Mihaela Tertiş, I. Crăciunescu, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1872-1872
Open Access | Times Cited: 34

Virus-like nanoparticles as a theranostic platform for cancer
Kyeong Rok Kim, Ae Sol Lee, Sumin Kim, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 10
Open Access | Times Cited: 23

Recent advances in mitochondria‐targeting theranostic agents
Kun Qian, Gao Shu, Zhaoning Jiang, et al.
Exploration (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 14

Exploiting temporal aspects of cancer immunotherapy
Rachael M. Zemek, Valsamo Anagnostou, Inês Pires da Silva, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 480-497
Closed Access | Times Cited: 13

Extracellular Matrix Components and Mechanosensing Pathways in Health and Disease
Aikaterini Berdiaki, Monica Neagu, Petros Tzanakakis, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1186-1186
Open Access | Times Cited: 11

Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
Mateusz Kciuk, Adrianna Gielecińska, Żaneta Kałuzińska‐Kołat, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189124-189124
Open Access | Times Cited: 8

Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer Mechanisms
Tianying Ren, Jing Wang, Yingxin Ma, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 66-66
Open Access | Times Cited: 1

Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy
Jie Liu, Bei Li, Li Li, et al.
Small (2024)
Closed Access | Times Cited: 7

An RNA damage response network mediates the lethality of 5-FU in colorectal cancer
Jung-Kuei Chen, Karl A. Merrick, Yi Wen Kong, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 10, pp. 101778-101778
Open Access | Times Cited: 7

A review on Persian Gulf brown algae as potential source for anticancer drugs
Abbas Sadeghi, Ali Rajabiyan, Najme Meygoli Nezhad, et al.
Algal Research (2024) Vol. 79, pp. 103446-103446
Closed Access | Times Cited: 6

Copper(ii) Complexes Based on 2,2’-Bipyridine and 1,10-Phenanthroline as Potential Objects for Developing Antitumor Drugs
Yu. A. Golubeva, Е.В. Лидер
Journal of Structural Chemistry (2024) Vol. 65, Iss. 6, pp. 1159-1209
Closed Access | Times Cited: 6

Curcumin as a hepatoprotective agent against chemotherapy-induced liver injury
Vicenç Ruiz de Porras, Mariona Figols, Albert Font, et al.
Life Sciences (2023) Vol. 332, pp. 122119-122119
Open Access | Times Cited: 13

Breast cancer and its genetic heterogeneity at single cell level: A concise perspective of cellular architecture and taxonomy
Riya Sharma, Neha Parihar, Keerti Gopi, et al.
Elsevier eBooks (2025), pp. 89-112
Closed Access

Quinoline and quinolone carboxamides: A review of anticancer activity with detailed structure–activity relationship analysis
Neethu Mariam Thomas, Majed Alharbi, Venkanna Muripiti, et al.
Molecular Diversity (2025)
Closed Access

Successful Pregnancy Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Malignancies
Haggai Benvenisti, Dan Assaf, Eyal Mor, et al.
European Journal of Surgical Oncology (2025), pp. 109725-109725
Closed Access

Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 12

Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer
Luis M. Ruiz‐Manriquez, Cynthia Villarreal‐Garza, Javier A. Benavides‐Aguilar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9984-9984
Open Access | Times Cited: 11

Phytometabolites as modulators of breast cancer: a comprehensive review of mechanistic insights
Priyanka Sharma, Khushi Gupta, Sumit Kumar Khandai, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 4

Mechanisms of Cancer Resistance to Various Therapies
Asiya Batool, Waseem Rashid, Kaneez Fatima, et al.
(2024), pp. 31-75
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top